In a world overrun by innovative biotechs, be a Mammoth Biosciences. Or a Nutcracker Therapeutics. Or Viking Therapeutics or Centessa Pharmaceuticals. I could go on and on and on with creative names of companies in this industry that are vibrant, fun and eye-catching. But most importantly, they make you overlook the potential scientific language barrier, the potential to not exactly understand what the company is doing at all, and make you want to learn more anyway.
Viking Therapeutics` weight-loss tablet shows promise in small study
Viking Announces Results from Phase 1 Trial of Oral Tablet Formulation
Viking Therapeutics Announces Closing of Public Offering of Common Stock
Truist raises Viking Therapeutics stock target to $120 on GLP1 profile
Viking data suggest obesity drug could rival Zepbound, Wegovy